• Bayer to Obtain Rights to Vitrakvi and BAY 2731954 americanpharmaceuticalreview
    February 18, 2019
    Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive licensing rights for the global development and commercialization...
PharmaSources Customer Service